Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
International Journal of Physiology and Pathophysiology
SJR: 0.106

ISSN Druckformat: 2155-014X
ISSN Online: 2155-0158

Archives: Volume 1, 2010 to Volume 9, 2018

International Journal of Physiology and Pathophysiology

DOI: 10.1615/IntJPhysPathophys.v6.i1.70
pages 61-68

Serum Levels of Endothelial Monocyte-Activating Polypeptide-II in type 2 Diabetes Mellitus

Liliya A. Mogylnytska
Khmelnytsky Regional Hospital, Khmelnytsky, Ukraine

ABSTRAKT

Endothelial dysfunction is implicated in the pathogenesis of macrovascular complications of diabetes and atherosclerosis. Endothelial monocyte-activating polypeptide-II (EMAP-II) is a multifunctional polypeptide with proinflammatory and antiangiogenic activity. The aim of the study was to investigate the serum level of EMAP-II in obese and non-obese patients with type 2 diabetes mellitus. We have found an increase in the serum level of EMAP-II in obese diabetic patients compared to obese subjects without diabetes, and in non-obese diabetic patients compared to control subjects. Moreover, a significant elevation of the serum EMAP-II in obese patients without diabetes compared to control subjects was observed. In obese and non-obese patients with diabetes mellitus, the serum levels of EMAP-II correlate significantly with HbAc1, blood glucose, body mass index, as well as with total cholesterol, LDL, HDL, and triglycerides. The revealed elevation of the serum level of EMAP-II reflects endothelial dysfunction in patients with type 2 diabetes mellitus. Hyperglycemia, dyslipidemia and obesity appear to be significant factors to contribute to elevation of EMAP-II level.


Articles with similar content:

Endothelial Monocyte Activating Peptide II: Serum Levels in Type 1 Diabetes Mellitus
International Journal of Physiology and Pathophysiology, Vol.8, 2017, issue 1
Liliya A. Mogylnytska, Olesya E. Mogylnytska
Nutrition and Diabetes Mellitus: How are They Interlinked?
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 4
Muhammad Sajid Hamid Akash, Kanwal Rehman
Effect of Probiotic Therapy on the Experimental Obesity Development in Rats Caused by Monosodium Glutamate
International Journal of Physiology and Pathophysiology, Vol.6, 2015, issue 2
O. V. Virchenko, Tetyana V. Beregova, L. P. Babenko, Tetyana M. Falalyeyeva, O.A. Savchenyuk, Mykola Ya. Spivak, L. M. Lazarenko
Partially Purified Aqueous Fraction of Desmodium gyrans DC Improves Reverse Cholesterol Transport and Lipoprotein Metabolism in Wistar Rats Fed with High Fat Diet
Journal of Environmental Pathology, Toxicology and Oncology, Vol.37, 2018, issue 1
Achuthan C. Raghavamenon, M. S. Indu, Jose Padikkala
A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.)Lloyd (Aphyllophoromycetideae) Extract in Patients with Type II Diabetes Mellitus
International Journal of Medicinal Mushrooms, Vol.6, 2004, issue 1
Jin Lan, Jingxian Ye, Yihuai Gao, Shufeng Zhou, Xihu Dai